Probi Ab

Göran Molin

Bengt Jeppsson

Siv Ahrné

Marcus Rudolf Götz

Anna Berggren

Siv Ahrne

Jörg Fischer

Caroline Karlsson

Alejandra Vasquez

Jörg Thilo Fischer

Siv Ahrn

The present invention relates to a novel bacterial strain,GOS 42 (DSM 32131), isolated preparations and compositions thereof; and their use in medicine, especially in the treatment and/or prevention of inflammation.

Probiotic bacterial strain ofand compositions and uses thereof in the treatment of inflammation

The invention refers to a composition comprising one or more tannase-producing strains of Lactobacillus having the ability to adhere to the human intestinal mucosa in combination with tannin. New tannase-producing strains of Lactobacillus plantarum are a.

Compositions comprisingstrains in combination with tannin and newstrains

The present invention relates to a probiotic bacterial strain belonging to the genushaving the ability to colonize the human vagina, or a variant thereof. More specifically the probiotic bacterial strain belongs to a species chosen from the group comprising, and. Further it relates to its use as a medicament, a composition comprising the strain, the composition, e.g., being a food product or a pharmaceutical composition, a hygiene product, a biological pure culture of the strain, and a novel food.

[object Object]

The invention refers to a composition comprising one or more tannase-producing strains ofhaving the ability to adhere to the human intestinal mucosa in combination with tannin. New tannase-producing strains ofare a.

Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains

Growing community of inventors

Lund, Sweden

Göran Molin